PRESS RELEASE Paris, 25th February 2026 Half-year results at the end of December 2025 Quality offering driving revenue growth, with continued efficiency supporting operational profitability Public funding to mitigate cost inflation still a challenge Group Revenue up 3.3% to €2.6bn (+2.3% LFL) from (i) a recognized quality offering driving volumes in France and (ii) strong fundamentals in the Nordics, with positive price indexation and favourable currency effects.Group EBITDA stable at €285m (11.0% margin) ...

Core Viewpoint - The private healthcare sector is facing significant challenges, with many hospitals closing, yet Lianchi Hospital in Shandong is attempting an IPO despite the downturn, showcasing a gross margin consistently above 30% [2][3] Group 1: Industry Challenges - Over 1,362 private hospitals have been closed or suspended in the first 11 months before 2025, averaging more than 7.5 closures per day, with over one-third being obstetrics and gynecology specialists [3] - Established medical device companies are divesting their hospital assets, indicating a shift in the industry landscape [2] Group 2: Lianchi Hospital's Business Model - Lianchi Hospital's business model focuses on "one old and one young," targeting both maternal and infant care and orthopedic services, which together account for over 90% of its revenue [4][10] - The maternal and infant care segment contributed 65.5% of revenue in 2024, with obstetric services seeing a 45.79% year-on-year increase [4][9] Group 3: Financial Performance - Lianchi Hospital's revenue grew from 356.43 million RMB in 2023 to 418.41 million RMB in 2024, with net profit increasing from 56.73 million RMB to 67.59 million RMB [14] - Despite the growth, the core hospitals in Qingdao and Zibo are experiencing revenue declines, with their combined revenue share dropping from 79.4% in 2023 to 60.0% in the first three quarters of 2025 [13][14] Group 4: Operational Challenges - The maternal and infant care segment is facing declining birth rates, leading to a drop in revenue and gross margin [10][11] - The orthopedic segment's revenue share decreased from 28.3% to 26.1%, with growth rates lagging behind overall revenue growth [11][12] Group 5: Financial Risks - Lianchi Hospital's goodwill has surged over 14 times from 15.09 million RMB to 231 million RMB, raising concerns about the sustainability of its high-margin business model [16][18] - The company's liquidity is under pressure, with cash on hand at 77.4 million RMB against current liabilities of 365 million RMB, indicating a potential cash flow crisis [18][19]

Core Viewpoint - Shares in Spire Healthcare increased by up to 20% following the confirmation of preliminary talks with multiple buyout firms, indicating strong market interest in a potential acquisition [1] Group 1: Company Developments - Spire Healthcare is engaged in initial discussions with several buyout firms, which has led to a significant rise in its stock price [1] - The confirmation of these talks has fueled expectations of a possible takeover, reflecting investor optimism about the company's future [1] Group 2: Market Reaction - The surge in Spire Healthcare's shares demonstrates a positive market reaction to the news of potential buyout discussions, highlighting investor confidence in the company's valuation [1]

Core Viewpoint - Spire Healthcare shares increased by 17% following the confirmation of preliminary talks with multiple buyout firms, including Bridgepoint and Triton, to explore strategic options [1][3]. Company Summary - Spire Healthcare is a British private hospital group that is currently in discussions with buyout firms to evaluate potential strategic alternatives [1][3].

Geopolitical Tensions - Russia launched a significant strike on Ukrainian drone sites and energy facilities, utilizing over 370 drones and 21 missiles, primarily targeting Kyiv's energy infrastructure, resulting in one fatality and two injuries [2] - Russian forces reportedly took control of Starytsya in Ukraine's Kharkiv region, although confirmed advances were not made on January 23 [3] Semiconductor Industry - Intel (INTC) is facing challenges despite significant investments from Nvidia ($5 billion), SoftBank ($2 billion), and the U.S. government ($8.9 billion converted to equity), which had previously boosted investor confidence [4] - Intel's shares fell 12-14% after forecasting first-quarter revenue and profit below market estimates, citing struggles to meet the booming demand for server chips used in AI data centers, leading to a net loss of $600 million in Q4 [5] AI Sector - Google (GOOGL) made a strategic investment in Japanese AI startup Sakana AI, valued at approximately $2.6 billion, to enhance the reach of its Gemini chatbot in Japan [6][7] - The partnership will leverage Alphabet's language models to improve product reliability and expand into critical sectors, including government agencies, with existing contracts with major Japanese financial institutions [8] Healthcare Sector - Buyout firms are exploring bids for Spire Healthcare (SPI), a UK private hospital operator, amid shareholder pressure, particularly from activist trust Achilles, who believe the company is undervalued [9][10] - Spire's market capitalization is around £672 million to £820 million, while its real estate assets are valued at over £1.4 billion, prompting a review of options to maximize shareholder value [10] Economic Outlook - ECB's Bundesbank President Joachim Nagel warned about the need for Europe to protect key industries against China and commented on the potential negative impact of U.S. tariffs on consumers [11][12] - Nagel expects modest growth in the German economy in Q1 2026, with inflation stabilizing at 2%, and anticipates increased government spending on defense and infrastructure to boost the economy later in 2026 and into 2027 [12]

Group 1 - The core focus of the article is that British private hospital group Spire Healthcare is in discussions with multiple buyout firms, including Bridgepoint and Triton Partners, regarding a potential takeover that may result in the company being taken private [1] Group 2 - The involvement of notable buyout firms such as Bridgepoint and Triton Partners indicates significant interest in Spire Healthcare from the private equity sector [1] - The potential takeover reflects ongoing trends in the healthcare industry, where private equity firms are increasingly targeting healthcare providers for investment opportunities [1] - The news highlights the strategic moves within the private hospital sector, suggesting a shift towards privatization for companies like Spire Healthcare [1]

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Lianchi Hospital Group Co., Ltd. 蓮池醫院集團股份有限公司 (the "Company") (A joint stock company incorporated in the People's R ...

Core Viewpoint - The article discusses a privacy breach incident involving a celebrity's childbirth information at Harmony Hospital, which the hospital denies, asserting no involvement from its medical staff in leaking patient privacy [1]. Group 1: Incident Overview - Harmony Hospital responded to allegations of a privacy leak regarding a celebrity's childbirth, stating there are no medical disputes or disagreements and denying any involvement from its staff in leaking patient information [1]. - The leaked information included details about the child's health and transfer to another hospital, which raised concerns about the source being medical personnel [1]. Group 2: Company Background - Harmony Medical, established nearly 30 years ago, began as a high-end obstetrics and gynecology provider and has since evolved into a comprehensive hospital, becoming a well-known high-end private medical institution in China [1]. - The hospital complements public medical institutions by attracting patients through service experience and high-value medical products, making it a preferred choice for celebrities and high-income families [1].

Core Viewpoint - Ramsay Health Care Limited has completed a strategic review regarding its majority shareholding in Ramsay Générale de Santé, with plans to execute one of the options considered and provide an update by February 2026 [1][2][3]. Group 1: Strategic Review - Ramsay Health Care Limited announced the completion of its strategic review with the assistance of Goldman Sachs [2]. - The Board and Management of Ramsay Health Care Limited are committed to executing one of the options from the strategic review [3]. - An update on the strategic options will be provided no later than the first half results publication in February 2026 [3]. Group 2: Company Overview - Ramsay Santé is the European leader in private hospitalization and primary care, employing 40,000 staff and 10,000 practitioners [4]. - The group serves 13 million patients annually across 492 facilities in five countries: France, Sweden, Norway, Denmark, and Italy [4]. - Ramsay Santé's mission encompasses a wide range of healthcare services, including medicine, surgery, obstetrics, rehabilitation, mental health, and primary care, focusing on innovation and equitable access to quality care [5].

Group 1 - The Combined General Meeting of Ramsay Générale de Santé is scheduled for December 11, 2025, at 10 a.m. in Paris [1] - The preliminary meeting notice was published on November 3, 2025, and includes the agenda, draft resolutions, and participation terms [2] - Shareholders can access all relevant documents on the company's website under the "Finance and investors / Shareholder's Meetings" section [3] Group 2 - Shareholders may submit written questions to the Chairman of the Board until December 5, 2025, via registered letter or email [4] - The General Meeting will be broadcast live and available for replay on the company's website [5] - Ramsay Santé is a leading European private hospitalization and primary care provider, employing 40,000 staff and serving 13 million patients annually across 492 facilities in five countries [6][7]